GeneBio Systems
Recombinant PI3 Kinase p85 alpha Monoclonal Antibody
Recombinant PI3 Kinase p85 alpha Monoclonal Antibody
SKU:AN301629L
Couldn't load pickup availability
Size::50μL
Storage:Store at -20℃ Valid for 12 months. Avoid freeze / thaw cycles.
Shipping:Ice bag
Exp date:12 months
Category ID_II:Primary Antibodies
Category ID_III:Monoclonal Antibodies;Recombinant Antibodies
Abbreviation:PI3 Kinase p85 alpha
Target Synonym:GRB;IMD;AGM;PIK3R;AGM7;GRB1;IMD36;p85;p85-ALPHA;PI3 Kinase p85 alpha;PIK3R1;p85 alpha;P85A;Phosphatidylinositol 3 kinase;Phosphatidylinositol 3 kinase associated p 85 alpha;Phosphatidylinositol 3 kinase regulatory 1;Phosphatidylinositol 3-kinase 85 kDa regulatory subunit alpha;Phosphatidylinositol 3-kinase regulatory subunit alpha;Phosphoinositide 3 kinase;PI3 kinase p85 subunit alpha;PI3K;PI3K regulatory subunit alpha;PI3-kinase regulatory subunit alpha;PI3-kinase subunit p85-alpha;polypeptide 1 (p85 alpha);PtdIns 3 kinase p85 alpha;PtdIns-3-kinase regulatory subunit alpha;PtdIns-3-kinase regulatory subunit p85-alpha;regulatory subunit;regulatory subunit 1 (alpha)
Research Areas:Signal Transduction;Cancer;Immunology;Metabolism
Conjugation:Unconjugated
Host:Rabbit
Species reactivity:Human;Mouse
Application:IHC;IF
Isotype:IgG,κ
Clonality:Monoclonal;Recombinant
Clone NO.:A332
UNIProt ID:P27986
Accession:
Background:Binds to activated (phosphorylated) protein-Tyr kinases, through its SH2 domain, and acts as an adapter, mediating the association of the p110 catalytic unit to the plasma membrane. Necessary for the insulin-stimulated increase in glucose uptake and glycogen synthesis in insulin-sensitive tissues. Plays an important role in signaling in response to FGFR1, FGFR2, FGFR3, FGFR4, KITLG/SCF, KIT, PDGFRA and PDGFRB. Likewise, plays a role in ITGB2 signaling. Modulates the cellular response to ER stress by promoting nuclear translocation of XBP1 isoform 2 in a ER stress- and/or insulin-dependent manner during metabolic overloading in the liver and hence plays a role in glucose tolerance improvement.
Concentration:1 mg/mL
Immunogen:Recombinant human PI3 Kinase p85 alpha fragment
Buffer:PBS, 50% glycerol, 0.05% Proclin 300, 0.05% protein protectant.
Purification method:Protein A purified
Dilution:IHC 1:50-1:100;IF 1:50
Calculated MW:
ObservedMW:
